LYFE Capital

LYFE Capital LYFE Capital operates as a transpacific healthcare investment platform with $2B total AUM, anchored by the $935M Fund IV (2022). With 5 global offices including Menlo Park and Singapore, the fund invests across therapeutics/pharma, life science tools/diagnostics, and medtech. Across 43 companies over 11 years, they average 4 new investments annually with a track record of 20+ IPOs and 10+ M&As covering 14+ medical specialties. The exits demonstrate the thesis working across geograph